I agree with your post and think we have the ball in our court. But it will only be in our court for those who will stick with biota because the travelling will NOT be without speed bumps and re-traces.
What I do like to see before I sign off on the above is some good feed back from those who took Inavir in Japan and how it helped them.
Because this will be the best kind of publicity DS and Biota wants to see, which will able them to spread their wings even further in the wide world (ROW) of antivirals.
Japan will be the showcase and if succesfull the rest of the world will follow suite.
And do not ask me how they are going to handle the ROW because imho we can expect the most unexpected from now on.
At the end I feel that the best possible outcome will be achieved for the benefit of all holders.
jojo
BTA Price at posting:
$1.28 Sentiment: LT Buy Disclosure: Held
